Skip to main content
TipRanks
Go Ultimate75% OFF

Ravi Jain Insider Profile

4 Followers

Ravi Jain, Senior Officer at Hemostemix, holds 388.90K shares in Hemostemix (Ticker: TSE:HEM). Most recently, Ravi Jain Sold 190,000 shares of Hemostemix on Jan 03, 2019 for an estimated value of C$11.16K.

Ravi Jain's Trading History

HEM
Hemostemix
Jan 03, 2019Senior OfficerInformative Sell11.16KC$13.61K
TSE:HEM
Insider Shares: 388.90K (58.04%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jan 03, 2019Informative Sell$11.16K190,000$0.06+84.70%―
Jan 01, 2019Informative Sell$7.46K140,000$0.05+87.50%―
Dec 24, 2018Informative Sell$26.23K430,000$0.06+88.20%―

You May Also Like

Ravi Jain insider profile FAQ

What is the percentage of profitable transactions made by Ravi Jain?
The percentage of profitable transactions made by Ravi Jain is 100%.
What is the average return per transaction made by Ravi Jain?
The average return per transaction made by Ravi Jain is 86.80%.
What stocks does Ravi Jain hold?
Ravi Jain holds: TSE:HEM stocks.
What was Ravi Jain’s latest transaction?
Ravi Jain’s latest transaction was an Informative Sell of C$11.16K.
What was Ravi Jain's most profitable transaction?
Ravi Jain’s most profitable transaction was an Informative Sell of TSE:HEM stock on December 24, 2018. The return on the trade was 88.20%.
What is Ravi Jain's role in Hemostemix?
Ravi Jain's role in Hemostemix is Senior Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.